Immune cell interactions in tuberculosis

JAL Flynn, J Chan - Cell, 2022 - cell.com
Despite having been identified as the organism that causes tuberculosis in 1882,
Mycobacterium tuberculosis has managed to still evade our understanding of the protective …

[HTML][HTML] Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis

TJ Scriba, MG Netea, AM Ginsberg - Seminars in immunology, 2020 - Elsevier
Tuberculosis is the leading infectious disease killer globally due to a single pathogen.
Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine …

[HTML][HTML] Prevention of tuberculosis in macaques after intravenous BCG immunization

PA Darrah, JJ Zeppa, P Maiello, JA Hackney… - Nature, 2020 - nature.com
Mycobacterium tuberculosis (Mtb) is the leading cause of death from infection worldwide.
The only available vaccine, BCG (Bacillus Calmette–Guérin), is given intradermally and has …

Intravenous Bacille Calmette–Guérin vaccination protects simian immunodeficiency virus-infected macaques from tuberculosis

EC Larson, AL Ellis-Connell, MA Rodgers… - Nature …, 2023 - nature.com
Tuberculosis, caused by Mycobacterium tuberculosis (Mtb), is the most common cause of
death in people living with human immunodeficiency virus (HIV). Intra-dermal Bacille …

Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB. 1.16 infection in nonhuman primates

M Gagne, BJ Flynn, SF Andrew, J Marquez… - Nature …, 2024 - nature.com
A mucosal route of vaccination could prevent severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) replication at the site of infection and limit transmission. We …

Vaccination against tuberculosis: revam** BCG by molecular genetics guided by immunology

SHE Kaufmann - Frontiers in immunology, 2020 - frontiersin.org
Tuberculosis (TB) remains a major health threat. Although a vaccine has been available for
almost 100 years termed Bacille Calmette-Guérin (BCG), it is insufficient and better vaccines …

MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates

JS Woodworth, V Contreras, D Christensen… - Nature …, 2024 - nature.com
Abstract Development of new vaccines tailored for difficult-to-target diseases is hampered by
a lack of diverse adjuvants for human use, and none of the currently available adjuvants …

Update on TB vaccine pipeline

C Martin, N Aguilo, D Marinova, J Gonzalo-Asensio - Applied Sciences, 2020 - mdpi.com
In addition to antibiotics, vaccination is considered among the most efficacious methods in
the control and the potential eradication of infectious diseases. New safe and effective …

[HTML][HTML] Markov field network model of multi-modal data predicts effects of immune system perturbations on intravenous BCG vaccination in macaques

S Wang, AJ Myers, EB Irvine, C Wang, P Maiello… - Cell Systems, 2024 - cell.com
Analysis of multi-modal datasets can identify multi-scale interactions underlying biological
systems but can be beset by spurious connections due to indirect impacts propagating …

Targeting immunometabolism in host defence against Mycobacterium tuberculosis

FJ Sheedy, M Divangahi - Immunology, 2021 - Wiley Online Library
In the face of ineffective vaccines, increasing antibiotic resistance and the decline in new
antibacterial drugs in the pipeline, tuberculosis (TB) still remains pandemic. Exposure to …